CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award Chief Financial Officer acquired 90,000 shares (grant or award)
- 4 Grant or award CEO acquired 210,000 shares (grant or award)
- 4 Planned sale CEO sold 101,793 shares at $4.54 ($461,906)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 12,255 shares at an average $2.72 ($33,381)
- 4 Open-market sale SVP, Chief Scientific Officer sold 13,884 shares at $2.69 ($37,334)
- 4 Open-market sale CEO sold 55,511 shares at $2.69 ($149,264)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 37,656 shares at $0.60 ($22,556)
Page 2 of 20 · 400 filings